Colgate Palmolive Co Financials
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Colgate Palmolive Co has an operating margin of 21.2%, meaning the company retains $21 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 20.5% the prior year.
Colgate Palmolive Co's revenue grew a modest 3.3% year-over-year to $20.1B. This slow but positive growth earns a score of 38/100.
Colgate Palmolive Co has elevated debt relative to equity (D/E of 34.38), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
Colgate Palmolive Co's current ratio of 0.92 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 17/100, which could limit financial flexibility.
Colgate Palmolive Co converts 17.6% of revenue into free cash flow ($3.5B). This strong cash generation earns a score of 88/100.
Colgate Palmolive Co earns a strong 1362.7% return on equity (ROE), meaning it generates $1363 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100. This is up from 377.7% the prior year.
Colgate Palmolive Co scores 7.39, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Colgate Palmolive Co passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Colgate Palmolive Co generates $1.42 in operating cash flow ($4.1B OCF vs $2.9B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Colgate Palmolive Co earns $14.6 in operating income for every $1 of interest expense ($4.3B vs $292.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
This page shows Colgate Palmolive Co (CL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Colgate Palmolive Co generated $20.1B in revenue in fiscal year 2024. This represents an increase of 3.3% from the prior year.
Colgate Palmolive Co's EBITDA was $4.9B in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.1% from the prior year.
Colgate Palmolive Co generated $3.5B in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 16.6% from the prior year.
Colgate Palmolive Co reported $2.9B in net income in fiscal year 2024. This represents an increase of 25.6% from the prior year.
Colgate Palmolive Co earned $3.51 per diluted share (EPS) in fiscal year 2024. This represents an increase of 26.7% from the prior year.
Colgate Palmolive Co held $1.1B in cash against $7.3B in long-term debt as of fiscal year 2024.
Colgate Palmolive Co paid $2.48 per share in dividends in fiscal year 2024. This represents an increase of 29.8% from the prior year.
Colgate Palmolive Co had 812M shares outstanding in fiscal year 2024. This represents a decrease of 1.4% from the prior year.
Colgate Palmolive Co's gross margin was 60.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 2.3 percentage points from the prior year.
Colgate Palmolive Co's operating margin was 21.2% in fiscal year 2024, reflecting core business profitability. This is up 0.7 percentage points from the prior year.
Colgate Palmolive Co's net profit margin was 14.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 2.5 percentage points from the prior year.
Colgate Palmolive Co's ROE was 1362.7% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 985.1 percentage points from the prior year.
Colgate Palmolive Co invested $355.0M in research and development in fiscal year 2024. This represents an increase of 3.5% from the prior year.
Colgate Palmolive Co spent $1.7B on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 54.2% from the prior year.
Colgate Palmolive Co invested $561.0M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 20.4% from the prior year.
CL Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B+0.4% | $5.1B+4.1% | $4.9B-0.7% | $4.9B-2.2% | $5.1B-0.1% | $5.1B+2.3% | $5.0B+0.7% | $4.9B |
| Cost of Revenue | $2.1B+2.0% | $2.0B+6.1% | $1.9B-2.0% | $2.0B-1.5% | $2.0B-1.7% | $2.0B+1.3% | $2.0B-1.9% | $2.0B |
| Gross Profit | $3.0B-0.7% | $3.1B+2.7% | $3.0B+0.2% | $3.0B-2.7% | $3.1B+0.9% | $3.0B+3.0% | $3.0B+2.5% | $2.9B |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $2.0B+0.4% | $2.0B+3.4% | $1.9B+0.2% | $1.9B-2.3% | $1.9B+1.2% | $1.9B+6.3% | $1.8B-1.0% | $1.8B |
| Operating Income | $1.1B-1.9% | $1.1B+0.4% | $1.1B+1.1% | $1.1B-2.6% | $1.1B+4.3% | $1.0B-2.3% | $1.1B+4.2% | $1.0B |
| Interest Expense | $67.0M-5.6% | $71.0M+7.6% | $66.0M-1.5% | $67.0M-14.1% | $78.0M+6.8% | $73.0M | N/A | N/A |
| Income Tax | $226.0M-3.4% | $234.0M+3.1% | $227.0M+5.1% | $216.0M-11.1% | $243.0M+2.1% | $238.0M+4.4% | $228.0M+9.1% | $209.0M |
| Net Income | $735.0M-1.1% | $743.0M+7.7% | $690.0M-6.5% | $738.0M+1.0% | $731.0M+7.0% | $683.0M-4.9% | $718.0M+1.4% | $708.0M |
| EPS (Diluted) | $0.910.0% | $0.91+7.1% | $0.85-4.5% | $0.890.0% | $0.89+7.2% | $0.83-3.5% | $0.860.0% | $0.86 |
CL Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.5B+0.2% | $17.5B+4.9% | $16.6B+3.7% | $16.0B-2.6% | $16.5B-0.5% | $16.6B+1.1% | $16.4B+2.2% | $16.0B |
| Current Assets | $6.0B+0.7% | $6.0B+3.1% | $5.8B+9.3% | $5.3B-5.8% | $5.6B+0.1% | $5.6B+6.8% | $5.3B-1.5% | $5.4B |
| Cash & Equivalents | $1.3B+5.3% | $1.2B+9.3% | $1.1B+1.5% | $1.1B-1.3% | $1.1B+2.9% | $1.1B+11.7% | $966.0M+1.6% | $951.0M |
| Inventory | $2.1B-0.5% | $2.1B-0.2% | $2.1B+6.9% | $2.0B+3.4% | $1.9B+0.4% | $1.9B-1.0% | $1.9B+0.2% | $1.9B |
| Accounts Receivable | $1.8B+1.9% | $1.8B+2.8% | $1.7B+13.4% | $1.5B-16.7% | $1.8B+0.7% | $1.8B+14.3% | $1.6B+0.6% | $1.6B |
| Goodwill | $3.7B+0.2% | $3.7B+10.9% | $3.3B+1.9% | $3.3B-1.4% | $3.3B-0.6% | $3.3B-2.0% | $3.4B+2.5% | $3.3B |
| Total Liabilities | $16.3B-0.9% | $16.4B+3.2% | $15.9B+2.7% | $15.5B-3.1% | $16.0B+0.3% | $16.0B+3.4% | $15.4B-1.3% | $15.6B |
| Current Liabilities | $6.5B-4.1% | $6.8B-1.3% | $6.9B+19.1% | $5.8B+7.6% | $5.3B+0.7% | $5.3B+12.1% | $4.7B+3.0% | $4.6B |
| Long-Term Debt | $7.3B+2.3% | $7.1B+8.7% | $6.6B-9.9% | $7.3B-10.5% | $8.1B-0.1% | $8.2B-0.8% | $8.2B-5.4% | $8.7B |
| Total Equity | $856.0M+21.9% | $702.0M+93.4% | $363.0M+71.2% | $212.0M+72.4% | $123.0M-46.5% | $230.0M-62.2% | $609.0M+6866.7% | -$9.0M |
| Retained Earnings | $27.1B+1.2% | $26.7B+1.2% | $26.4B+1.0% | $26.1B+2.6% | $25.5B+1.3% | $25.2B-0.5% | $25.3B+2.9% | $24.6B |
CL Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B+42.6% | $884.0M+47.3% | $600.0M-52.7% | $1.3B+28.2% | $990.0M+45.4% | $681.0M-40.1% | $1.1B-1.4% | $1.2B |
| Capital Expenditures | $155.0M+43.5% | $108.0M-12.9% | $124.0M-32.6% | $184.0M+57.3% | $117.0M-7.1% | $126.0M-36.0% | $197.0M+22.4% | $161.0M |
| Free Cash Flow | $1.1B+42.5% | $776.0M+63.0% | $476.0M-56.1% | $1.1B+24.3% | $873.0M+57.3% | $555.0M-40.9% | $939.0M-5.2% | $991.0M |
| Investing Cash Flow | -$154.0M+61.6% | -$401.0M-152.2% | -$159.0M-98.8% | -$80.0M+27.9% | -$111.0M+42.5% | -$193.0M-35.0% | -$143.0M+11.2% | -$161.0M |
| Financing Cash Flow | -$1.0B-151.3% | -$409.0M+10.7% | -$458.0M+64.2% | -$1.3B-51.4% | -$845.0M-134.1% | -$361.0M+63.6% | -$992.0M-17.3% | -$846.0M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $288.0M+24.1% | $232.0M-18.3% | $284.0M-37.6% | $455.0M-5.2% | $480.0M-5.7% | $509.0M+107.8% | $245.0M-26.2% | $332.0M |
CL Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.4%-0.6pp | 60.1%-0.8pp | 60.8%+0.5pp | 60.3%-0.3pp | 60.6%+0.6pp | 60.0%+0.4pp | 59.6%+1.1pp | 58.5% |
| Operating Margin | 20.6%-0.5pp | 21.1%-0.8pp | 21.9%+0.4pp | 21.5%-0.1pp | 21.6%+0.9pp | 20.7%-1.0pp | 21.7%+0.7pp | 20.9% |
| Net Margin | 14.3%-0.2pp | 14.5%+0.5pp | 14.1%-0.9pp | 14.9%+0.5pp | 14.4%+1.0pp | 13.5%-1.0pp | 14.5%+0.1pp | 14.4% |
| Return on Equity | 85.9%-20.0pp | 105.8%-84.2pp | 190.1%-158.0pp | 348.1%-246.2pp | 594.3%+297.4pp | 297.0%+179.1pp | 117.9% | N/A |
| Return on Assets | 4.2%-0.1pp | 4.3%+0.1pp | 4.1%-0.5pp | 4.6%+0.2pp | 4.4%+0.3pp | 4.1%-0.3pp | 4.4%-0.0pp | 4.4% |
| Current Ratio | 0.93+0.0 | 0.89+0.0 | 0.85-0.1 | 0.92-0.1 | 1.060.0 | 1.06-0.1 | 1.11-0.1 | 1.16 |
| Debt-to-Equity | 8.54-1.6 | 10.18-7.9 | 18.10-16.3 | 34.38-31.8 | 66.23+30.8 | 35.44+21.9 | 13.50+979.1 | -965.56 |
| FCF Margin | 21.6%+6.4pp | 15.2%+5.5pp | 9.7%-12.3pp | 21.9%+4.7pp | 17.3%+6.3pp | 11.0%-8.0pp | 19.0%-1.2pp | 20.2% |
Note: The current ratio is below 1.0 (0.92), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Colgate Palmolive Co's annual revenue?
Colgate Palmolive Co (CL) reported $20.1B in total revenue for fiscal year 2024. This represents a 3.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Colgate Palmolive Co's revenue growing?
Colgate Palmolive Co (CL) revenue grew by 3.3% year-over-year, from $19.5B to $20.1B in fiscal year 2024.
Is Colgate Palmolive Co profitable?
Yes, Colgate Palmolive Co (CL) reported a net income of $2.9B in fiscal year 2024, with a net profit margin of 14.4%.
What is Colgate Palmolive Co's earnings per share (EPS)?
Colgate Palmolive Co (CL) reported diluted earnings per share of $3.51 for fiscal year 2024. This represents a 26.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Colgate Palmolive Co's EBITDA?
Colgate Palmolive Co (CL) had EBITDA of $4.9B in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Colgate Palmolive Co have?
As of fiscal year 2024, Colgate Palmolive Co (CL) had $1.1B in cash and equivalents against $7.3B in long-term debt.
What is Colgate Palmolive Co's gross margin?
Colgate Palmolive Co (CL) had a gross margin of 60.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Colgate Palmolive Co's operating margin?
Colgate Palmolive Co (CL) had an operating margin of 21.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Colgate Palmolive Co's net profit margin?
Colgate Palmolive Co (CL) had a net profit margin of 14.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does Colgate Palmolive Co pay dividends?
Yes, Colgate Palmolive Co (CL) paid $2.48 per share in dividends during fiscal year 2024.
What is Colgate Palmolive Co's return on equity (ROE)?
Colgate Palmolive Co (CL) has a return on equity of 1362.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Colgate Palmolive Co's free cash flow?
Colgate Palmolive Co (CL) generated $3.5B in free cash flow during fiscal year 2024. This represents a 16.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Colgate Palmolive Co's operating cash flow?
Colgate Palmolive Co (CL) generated $4.1B in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Colgate Palmolive Co's total assets?
Colgate Palmolive Co (CL) had $16.0B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Colgate Palmolive Co's capital expenditures?
Colgate Palmolive Co (CL) invested $561.0M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Colgate Palmolive Co spend on research and development?
Colgate Palmolive Co (CL) invested $355.0M in research and development during fiscal year 2024.
Does Colgate Palmolive Co buy back shares?
Yes, Colgate Palmolive Co (CL) spent $1.7B on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
How many shares does Colgate Palmolive Co have outstanding?
Colgate Palmolive Co (CL) had 812M shares outstanding as of fiscal year 2024.
What is Colgate Palmolive Co's current ratio?
Colgate Palmolive Co (CL) had a current ratio of 0.92 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Colgate Palmolive Co's debt-to-equity ratio?
Colgate Palmolive Co (CL) had a debt-to-equity ratio of 34.38 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Colgate Palmolive Co's return on assets (ROA)?
Colgate Palmolive Co (CL) had a return on assets of 18.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Colgate Palmolive Co's Altman Z-Score?
Colgate Palmolive Co (CL) has an Altman Z-Score of 7.39, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Colgate Palmolive Co's Piotroski F-Score?
Colgate Palmolive Co (CL) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Colgate Palmolive Co's earnings high quality?
Colgate Palmolive Co (CL) has an earnings quality ratio of 1.42x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Colgate Palmolive Co cover its interest payments?
Colgate Palmolive Co (CL) has an interest coverage ratio of 14.6x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Colgate Palmolive Co?
Colgate Palmolive Co (CL) scores 57 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.